# Dimiracetam in Painful Neuropathies Affecting AIDS Patients

> **NCT01444690** · PHASE2 · UNKNOWN · sponsor: **Neurotune AG** · enrollment: 244 (estimated)

## Conditions studied

- Acquired Immunodeficiency Syndrome

## Interventions

- **DRUG:** Dimiracetam
- **DRUG:** Dimiracetam 25 mg

## Key facts

- **NCT ID:** NCT01444690
- **Lead sponsor:** Neurotune AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 244 (ESTIMATED)
- **Last updated:** 2011-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01444690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01444690, "Dimiracetam in Painful Neuropathies Affecting AIDS Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01444690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*